Pharmaceutical giant GlaxoSmithKline will shutter its Clifton oral care manufacturing plant on Thursday, and lay off 165 employees, the London-based firm confirmed today. The plant closure is part ...

GlaxoSmithKline has introduced a new toothpaste delivery system that disperses active ingredients quickly, penetrating hard-to-reach areas of the mouth, according to the company. Iso-active, which is ...

Colgate-Palmolive has filed a lawsuit in federal court defending its right to use a "nurdle" image and the phrase "Triple Action" on its toothpaste packaging, according to a story in the Wall Street ...

GSK PLC completed the spinoff of its consumer-healthcare business, a bet that greater focus on innovative drugs and vaccines will help accelerate growth at the pharmaceuticals giant. The new stand ...

Bite toothpaste bits are nontoxic, plastic-free and made from science-backed ingredients, perfect for anyone who wants to reduce waste and break away from plastic tubes.

GlaxoSmithKline is "firmly on track" to spin off its consumer health business next year, ... The division, which makes Sensodyne toothpaste, and Advil and Panadol painkillers, ...

GSK is fully exiting its position and will no longer hold any ordinary shares in Haleon, maker of Sensodyne toothpaste and Advil painkillers.

GlaxoSmithKline's consumer health business will be named Haleon following its planned spinoff and listing on the London Stock Exchange later this year, according to the drugmaker. The name of the ...

This morning, GlaxoSmithKline and Pfizer announced a mega-deal, merging their consumer products divisions, which sell everything from Chapstick to Sensodyne toothpaste to Centrum vitamins to ...

GSK will hold approximately 385 million shares, representing approximately 4.2% of Haleon. The current disposal marks that GSK has sold a stake in the Sensodyne toothpaste maker for the third time ...

GSK plc (NYSE: GSK) has completed the demerger of the Consumer Healthcare business to form the Haleon Group. Reuters reported that shares in Haleon started trading at 330 pence on Monday morning ...

GSK has sold its remaining stake in Haleon, the consumer healthcare company it spun off and listed in London in July 2022, raising £1.25bn and underscoring how pharmaceutical groups are ...